8 Pulmonary Hypertension Clinical Trials in Fresno, CA (2026)

Q: How do I join a clinical trial in Fresno?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Fresno research site will contact you.

Recruiting Pulmonary Hypertension Studies in Fresno

NCT06628908Recruiting

Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabetic peripheral neuropathy (DPN)....

Fresno, CAPHASE31,100 participantsVertex Pharmaceuticals Incorporated

View Study Details

NCT06191744Recruiting

Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma

Follicular lymphoma (FL) is the second most common B-cell cancer and the most common type of cancer of lymphocytes. Unfortunately, this disease is incurable with conventional treatment and the disease...

Fresno, CAPHASE31,095 participantsGenmab

View Study Details

NCT06742996Recruiting

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma

The goal of this study is to compare how well sonrotoclax plus zanubrutinib works versus zanubrutinib plus placebo in treating adults with relapsed/refractory (R/R) mantle cell lymphoma (MCL). This st...

Fresno, CAPHASE3300 participantsBeiGene

View Study Details

NCT04757116Recruiting

Post-Market Study to Assess iTind Safety in Comparison to UroLift

The study objective is to evaluate the safety of the iTind device comparied to UroLift....

Fresno, CANA206 participantsOlympus Corporation of the Americas

View Study Details

NCT06962800Recruiting

A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)

In this study, researchers will learn more about the use of felzartamab in participants with primary membranous nephropathy, also known as PMN. In people with PMN, autoantibodies build up in the glome...

Fresno, CAPHASE3180 participantsBiogen

View Study Details

NCT06029270Recruiting

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

This phase II trial tests the addition of BMS-986016 (relatlimab) to the usual immunotherapy after initial treatment for nasopharyngeal cancer that has come back after a period of improvement (recurre...

Fresno, CAPHASE2156 participantsNational Cancer Institute (NCI)

View Study Details

NCT06129240Recruiting

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

Study LTI-401 is an open-label, multicenter study which will evaluate the safety and tolerability of LIQ861 in subjects who have WHO Group 1 \& 3 PH....

Fresno, CA80 participantsLiquidia Technologies, Inc.

View Study Details

NCT06712407Recruiting

Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy

The goal of this clinical trial is to assess the efficacy and safety of extended TARPEYO® (delayed-release budesonide capsules) treatment in adult patients with primary IgA nephropathy who have comple...

Fresno, CAPHASE460 participantsCalliditas Therapeutics AB

View Study Details

About Pulmonary Hypertension Clinical Trials in Fresno

Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.

There are currently 8 pulmonary hypertension clinical trials recruiting participants in Fresno, CA. These studies are seeking a combined 3,177 participants. Research is being sponsored by Vertex Pharmaceuticals Incorporated, Genmab, BeiGene and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Hypertension Clinical Trials in Fresno — FAQ

Are there pulmonary hypertension clinical trials in Fresno?

Yes, there are 8 pulmonary hypertension clinical trials currently recruiting in Fresno, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Fresno?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fresno research site will contact you about next steps.

Are clinical trials in Fresno free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fresno studies also compensate for your time and travel.

What pulmonary hypertension treatments are being tested?

The 8 active trials in Fresno are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.

Data updated July 19, 2026 from ClinicalTrials.gov